Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

scientific article

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(94)90988-1
P698PubMed publication ID7904666

P2093author name stringR Seshadri
E Hughes
G Tauro
H Ekert
I Toogood
J Condon
K Waters
M J Brisco
P J Sykes
S H Neoh
P2860cites workPrimer-directed enzymatic amplification of DNA with a thermostable DNA polymeraseQ26778389
Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasmsQ33877226
Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probesQ34287703
Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemiasQ35818509
Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimensQ37258487
The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.Q41086307
Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal populationQ41731494
Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reactionQ43674387
Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders.Q50796956
Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemiaQ67594845
Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcomeQ68068753
Detection of minimal residual disease in childhood leukemia with the polymerase chain reactionQ68203153
Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatmentQ70292275
P433issue8891
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
P304page(s)196-200
P577publication date1994-01-01
P1433published inThe LancetQ939416
P1476titleOutcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
P478volume343